P01067 AF NFT

Bowman-Birk type proteinase inhibitor B-II

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiacoync4zojyoc7sldj6axtluatmjmkjdr3g2ik5wfoqhlqa4zita/metadata.json
IPFS of structure file: 
bafybeicuji5d2yn4xgesr2yse4pucu2j3b3kgvfrl43sqomxl5nvuiw7vi/AF-P01067-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x3DcF12Af844D20c57A4baBD2d4DA6420B9225E45
First NFT owner address (bech32): 
genesis18h839tuyf5sv27jt40fdfknyyzujyhj9mx6cyx
Current NFT ID #183029 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
183029
Accession (UniProt):
P01067
Name::
Bowman-Birk type proteinase inhibitor B-II
Experimental Method:
Predicted structure
Sequence source:
ARACHIS HYPOGAEA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P01067 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P01067|IBB2_ARAHY Bowman-Birk type proteinase inhibitor B-II OS=Arachis hypogaea OX=3818 PE=1 SV=1 AASDCCSACICDRRAPPYFECTCGDTFDHCPAACNKCVCTRSIPPQCRCTDRTQGRCPLTPCA